EARLY Routine Catheterization After Alteplase Fibrinolysis vs. PPCI in ST-Segment-Elevation MYOcardial Infarction
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 344 participants.
Also called NCT01930682
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 344 participants
- Sponsor
- Registry
-
NCT01930682
-
- Other papers using this trial's data
- Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction)
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01930682. Randomized; single masking; primary purpose treatment. Start 2014-01-13 (actual); primary completion 2016-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- EARLY Routine Catheterization After Alteplase Fibrinolysis vs. PPCI in ST-Segment-Elevation MYOcardial Infarction
- Acronym
- EARLY-MYO
- Condition
- Acute ST-segment Elevation Myocardial Infarction
- Intervention (Drug)
- Alteplase
- Intervention (Procedure)
- Early post-fibrinolytic catheterisation
- Intervention (Procedure)
- Primary PCI (percutaneous coronary intervention)
- Lead sponsor
- RenJi Hospital
Record details
- Record id
cardio:ct-nct01930682- Content hash
f49f1812f3908e15d5cb791e7abcd523b490e11f716342813ceef6ed7e4e60a4